Cargando…
Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications
BACKGROUND: Pediatric Mastocytosis is a rare and heterogeneous disease, characterized by accumulation of mast cells in the skin (Cutaneous Mastocytosis) and/or, less frequently, in other organs, mainly liver, spleen, bone marrow, lymph nodes and gastrointestinal tract (Systemic Mastocytosis). Patien...
Autores principales: | Bossi, Grazia, Brazzelli, Valeria, De Amici, Mara, Pietra, Daniela, Raviola, Chiara, Naso, Matteo, Regalbuto, Corrado, Boselli, Federica, Fortina, Valeria, Marseglia, Gian Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839392/ https://www.ncbi.nlm.nih.gov/pubmed/36639823 http://dx.doi.org/10.1186/s13052-022-01402-7 |
Ejemplares similares
-
Omalizumab as a corticosteroid‐sparing agent in the treatment of bullous pemphigoid
por: Vassallo, Camilla, et al.
Publicado: (2022) -
Efficacy of Omalizumab in Indolent Systemic Mastocytosis
por: Slapnicar, Calum, et al.
Publicado: (2019) -
Omalizumab in Children
por: Licari, Amelia, et al.
Publicado: (2014) -
Omalizumab in Children with Severe Allergic Asthma: The Italian Real-Life Experience
por: Licari, Amelia, et al.
Publicado: (2017) -
Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
por: Bossi, Grazia, et al.
Publicado: (2022)